Susan Hasty, Publisher
Table of Contents . . . October 21st, 1996Non-Subscriber - Summaries Only
Conference Coverage (ICAAC) - CDC: "Missed Opportunities" Led to Increase in Hepatitis B
Conference Coverage (ICAAC) - Diphtheria Epidemic Ending in Former U.S.S.R., U.S. Elimination Near
Conference Coverage (ICAAC) - FDA: Hepatitis B Vaccine Safe In Infants
Conference Coverage (ICAAC) - HIV Increase After Vaccination Inconsistent and Transient
Conference Coverage (ICAAC) - HIV+ Children Rapidly Lose Antibodies to Bacterial Vaccines
Conference Coverage (ICAAC) - Hepatitis A Vaccination: Cost Effective for Physicians?
Conference Coverage (ICAAC) - Pneumonia Vaccines Worth the Effort, CDC Researcher Says
Cancer Vaccines - Phase I/II Trial for MGV Cancer Vaccine Begins
Cancer Vaccines - Trial Approval Received for Ovarex Vaccine in Canada
HAV Vaccines - Vaqta Vaccine Could Eradicate Hepatitis A
HBV Vaccines - Contract Awarded for Hepatitis B Adult Vaccine
Immunization - Vaccination Encouraged Against Pneumonia and Influenza
International (Africa) - Yellow Fever Rises Dramatically
International (Europe) - Young Europeans Unaware of Hepatitis B Risk
Pediatrics (Immunization) - Acellular Pertussis Vaccine Licensed for Reconstitution with Haemophilus Vaccine
Pediatrics (Immunization) - PLA Submitted for Genetically Engineered Vaccine
Vaccines (Development) - Fellowship Awarded To Develop Combination DTP Vaccine
Immunology (Vaccines) - "Immunogenicity of Hepatitis B and Influenza Vaccines."
Pathogenesis (Mycobacterium) - "Differential Induction of Chemokine mRNA (MIP-2, KC and MIP-1 (beta)) by Mycobacterium tuberculosis ENDITAL
Vaccine Development (CMV) - "A New Generation of Live, Attenuated Cytomegalovirus (CMV) Vaccine Strains."
Vaccine Development (EBV) - "Recombinant EBV gp350 as a Subunit Vaccine Candidate to Prevent EBV-Related Disease."